Oligonucleotide-based Therapies Market, Global Outlook and Forecast 2023-2030
Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.
Although several types of oligonucleotide therapies exist, five of them are compared here, including the ones targeting nucleic acids (such as mRNA) or proteins, as well as others intended for stimulation of the immune system. DDS is generally used with oligonucleotide therapy, as it is difficult for these molecules to penetrate cell membrane when administered on their own.
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide-based Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide-based Therapies. This report contains market size and forecasts of Oligonucleotide-based Therapies in global, including the following market information:
Global Oligonucleotide-based Therapies Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Oligonucleotide-based Therapies market was valued at US$ 3784.6 million in 2022 and is projected to reach US$ 7626 million by 2029, at a CAGR of 10.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Biogen is the industry's biggest player, with more than 76 percent of 2018 revenue, followed by Sarepta Therapeutics and Jazz Pharmaceuticals, with 13.35 percent and 6.63 percent, respectively. North America and Europe are the most important regions, accounting for more than 80 percent of the combined income.
We surveyed the Oligonucleotide-based Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oligonucleotide-based Therapies Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Oligonucleotide-based Therapies Market Segment Percentages, by Type, 2022 (%)
Antisense Oligonucleotide
Aptamer
Other
Global Oligonucleotide-based Therapies Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Oligonucleotide-based Therapies Market Segment Percentages, by Application, 2022 (%)
Neuromuscular Diseases
Hepatic VOD
Other
Global Oligonucleotide-based Therapies Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Oligonucleotide-based Therapies Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oligonucleotide-based Therapies revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Oligonucleotide-based Therapies revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen
Sarepta Therapeutics
Jazz Pharmaceuticals
Bausch & Lomb
Alnylam Pharmaceuticals
Dynavax Technologies
Kastle therapeutics
Akcea Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oligonucleotide-based Therapies, market overview.
Chapter 2: Global Oligonucleotide-based Therapies market size in revenue.
Chapter 3: Detailed analysis of Oligonucleotide-based Therapies company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oligonucleotide-based Therapies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
